1·Study the early death reason in patients with acute promyelocytic leukemia.
探讨急性早幼粒细胞白血病患者早期死亡原因。
2·Study the early death reason in patients with acute promyelocytic leukemia (APL).
探讨急性早幼粒细胞白血病（APL）患者早期死亡原因。
3·Objective:To study the early death reason in patients with acute promyelocytic leukemia (APL).
目的：探讨急性早幼粒细胞白血病（APL）患者早期死亡原因。
4·Targeting peroxiredoxin I/II by Adenanthin, a naturally occurring diterpenoid, to induce differentiation and eradicate leukemia-initiating cells of acute promyelocytic leukemia.
靶向过氧化物酶I/II，一种天然二帖类物质，诱导分化和根除急性早幼粒细胞白血病。
5·Objective To study the morphologic and cytogenetic change in acute promyelocytic leukemia (APL) patients during the tetra arsenic tetra sulfide (TATS) treatment and the mechanism of TATS.
目的观察四硫化四砷（TATS）治疗初治和复发急性早幼粒细胞白血病（APL）过程中细胞形态学及细胞遗传学变化，探讨其作用机制。